{{Rsnum
|rsid=7004633
|Chromosome=8
|position=88748082
|Orientation=plus
|GMAF=0.2837
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 70.8 | 24.8 | 4.4
| HCB | 61.3 | 34.3 | 4.4
| JPT | 69.0 | 28.3 | 2.7
| YRI | 26.7 | 43.8 | 29.5
| ASW | 37.5 | 46.4 | 16.1
| CHB | 61.3 | 34.3 | 4.4
| CHD | 67.6 | 25.9 | 6.5
| GIH | 48.5 | 43.6 | 7.9
| LWK | 42.6 | 44.4 | 13.0
| MEX | 43.1 | 44.8 | 12.1
| MKK | 44.9 | 42.9 | 12.2
| TSI | 49.5 | 42.6 | 7.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21926974
|Trait=None
|Title=Genome-wide association study identifies five new schizophrenia loci.
|RiskAllele=A
|Pval=2E-7
|OR=1.1100
|ORtxt=[1.07-1.15]
|OA=1
}}

{{PMID Auto GWAS
|PMID=22688191
|Trait=None
|Title=Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
|RiskAllele=
|Pval=6E-8
|OR=1.1500
|ORtxt=None
|OA=1
}}

{{PMID Auto GWAS
  |PMID=23453885
  |Trait=Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
  |Title=Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
  |RiskAllele=
  |Pval=3E-8
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{PMID Auto
|PMID=23490065
|Title=A population-based association study of 2q32.3 and 8q21.3 loci with schizophrenia in Han Chinese
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}